IL-10R mutations associated with inflammatory bowel disease (IL-10 and IL-10 receptor mutations in very early-onset inflammatory bowel disease) lead to the loss of the inhibitory effect of IL-10 on proinflammatory cytokine production in patient cells. This evidence concerns the gene IL10RA and inflammatory bowel disease.